Patent Assignment
Reel/Frame 050072/0389
Assignment of Assignor's Interest
Recorded: 2019-08-16
Pages: 12
Assignors
GILLIGAN, JAMES P.
Executed: 2017-07-13
MAURER, GEORGE R.
Executed: 2017-07-13
RAILKAR, ANIRUDDHA M.
Executed: 2017-07-13
BAUER, PHIL
Executed: 2017-07-13
Assignee
TARSA THERAPEUTICS, INC.
8 PENN CENTER, 1628 JOHN F. KENNEDY BOULEVARD, SUITE 1400, PHILADELPHIA, PENNSYLVANIA, 19103
Covered Property
(1)
Room Temperature Stable Oral Calcitonin Formulation
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 16, 2019
From: DAGGS, THOMAS A.; SHIELDS, PAUL P.
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 050072/0341 →
Assignment of Assignor's Interest
Aug 16, 2019
From: TARSA THERAPEUTICS, INC.
To: TAURUS DEVELOPMENT COMPANY LLC
Reel/Frame 050072/0425 →
Security Interest
Aug 26, 2019
From: ENTERIS BIOPHARMA, INC.
To: CADENCE BANK, N.A.
Reel/Frame 050174/0428 →
Assignment of Assignor's Interest
Jan 5, 2023
From: TAURUS DEVELOPMENT COMPANY LLC
To: PARK THERAPEUTICS, INC.
Reel/Frame 062287/0841 →
Release of Security Interest
Jun 28, 2023
From: CADENCE BANK, A MISSISSIPPI BANK AND SUCCESSOR BY MERGER TO CADENCE BANK, N.A., A NATIONAL BANKING ASSOCIATION, AS AGENT
To: ENTERIS BIOPHARMA, INC.
Reel/Frame 064149/0741 →
Corrective Assignment to Correct the the Assignment Previously Recorded Previously Recorded at Reel: 068713 Frame: 0499. Assignor(S) Hereby Confirms the Assignment.
Oct 24, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 070760/0864 →